Live Cell Encapsulation Market Research Report - Global Forecast till 2027

Live Cell Encapsulation Market Size, Growth and Trends Analysis By Manufacturing Technique (Simple Dripping, Electrostatic Dripping, & Others), Polymer Type (Alginate, HEMA-MMA, Chitosan, PAN-PVC, & Others), Application (Drug Delivery & Others)-Forecast till 2027

ID: MRFR/HC/6302-HCR | February 2021 | Region: Global | 160 pages

Live Cell Encapsulation Market Scenario

The Live Cell Encapsulation Market is expected to register a CAGR 3.22% during the forecast period of 2018 to 2023, with an estimated market value of USD 249.87 million in 2017.

The global market is driven by factors such as rising demand for clinical efficacy of cell encapsulation technologies and growing awareness related to the clinical role of encapsulated cells to treat different chronic diseases. Additionally, encapsulation provides the durability and stability of the nutrient during handling and storage. Thus, such benefits of this technique are luring the competitors to enter the market.

On the other hand, the lack of skilled technicians, ethical issues, and unaffordability of research organizations and small-scale companies in certain economies is restraining the growth of live cell encapsulation market. Moreover, the availability of high-quality raw material is also restraining the growth of the market. Nevertheless, changes in regulatory policies and rise in demand for effective therapies to treat complicated disorders is expected to reduce the impact of barriers over the forecast period.

Moreover, major companies in the market are involved in strategic collaborations to brace their position in the market. For instance, in August 2018, Balchem Italia S.r.l., a wholly owned subsidiary of Balchem Corporation, acquired Bioscreen Technologies, S.r.l., a privately held manufacturer of encapsulated and fermented feed nutrition ingredients. With this, the company aims to expand its position in the market.


The Live Cell Encapsulation Market has been segmented into manufacturing technique, polymer type, and application. The market, based on manufacturing technique, has been segmented into simple dripping, electrostatic dripping, coaxial airflow, rotating disk atomization, and others. The market, by polymer type, has been further segmented into alginate, HEMA-MMA, Chitosan, silica, cellulose sulfate, PAN-PVC, and others. The market, by application, has been segmented into drug delivery, regenerative medicine, cell transplantation, and others. The drug delivery segment is expected to hold a major share owing to the increasing use of live cell encapsulation techniques in drug delivery systems. The segment of regenerative medicine is expected to be the fastest growing segment due to the rising trend and benefits of encapsulation in the tissue engineering field.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The live cell encapsulation market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada. The European market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The live cell encapsulation market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key Players

Balchem Corporation, Evonik Industries, Merck KGaA, BÜCHI Labortechnik AG, Lycored, Blacktrace Holdings Ltd., Living Cell Technologies, Reed Pacific Pty Limited, MiKroCaps, Biotime, Inc., Neurotech Holdings, LLC, Sernova Corporation, Encapsys, LLC, Sigilon Therapeutics, Inc., and Viacyte, Inc. are some of the key players in the global live cell encapsulation market.

Regional Market Summary

Global Live Cell Encapsulation Market Share (%), by Region, 2017

Global Live Cell Encapsulation Market Share (%), by Region, 2017

Source: World Health Organization (WHO), Institute of Medicine (IOM)

Geographically, the Americas is expected to dominate the global live cell encapsulation market due to the increasing per capita healthcare expenditure, and the heavy adoption of new technology.

Furthermore, rising expenses in research and development by healthcare bodies and the government is anticipated to drive the growth of the market in this region. Apart from this, increasing applications of regenerative medicine in the US is expecting to push the growth of live cell encapsulation market. For instance, According to the National Institutes of Health (NIH), approximately 5,00,000 Americans benefit from a transplant each year.

Europe showed a considerable amount of growth in the global live cell encapsulation market. The market growth in this region is because of the presence of a well-established healthcare system and increase in chronic diseases. For instance, according to cancer research UK, there were approximately 9, 921 cases of cancer diagnosed in 2015. Such high rates of cancer are likely to increase demand for the use of next-generation sequencing as well as increase the market demands for monoclonal bodies and cellular research. These factors are expected to have a positive impact on the live cell encapsulation market.

Asia-Pacific is expected to have a sturdy growth rate during the forecast period owing to the huge patient pool of chronic diseases and government initiatives of healthcare reforms. However, less capital investment is restricting the market growth of this region.

On the other hand, the Middle East & Africa has the least share of the market due to the low disposable income. Moreover, the limited adoption of advanced healthcare facilities and limited access to treatment facilities is also expected to drive the growth of the market in the near future.

Global Live Cell Encapsulation Market, by Manufacturing Technique

  • Simple Dripping

  • Electrostatic Dripping

  • Coaxial Airflow

  • Rotating Disk Atomization

  • Others

Global Live Cell Encapsulation Market, by Application

  • Drug Delivery

  • Regenerative Medicine

  • Cell Transplantation

  • Others 

Global Live Cell Encapsulation Market, by Region

  • Americas

    • North America

      • US

      • Canada

    • Latin America

  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe

    • Eastern Europe

  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific

  • Middle East & Africa

    • Middle East

    • Africa

Intended Audience

  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Government Research Institute

  • Academic Institutes and Universities

  • Venture Capitalists

Speak to Analyst Ask for Customization

Frequently Asked Questions (FAQ) :

Live cell encapsulation market was valued at USD 249.87 million in 2017.

The global market is expected to exhibit a steady 3.22% CAGR over the forecast period from 2018 to 2023.

Growing awareness about the possibility of using encapsulated cells to treat various chronic diseases is the major driver for the global cell encapsulation market.

Difficulties in acquiring high-quality raw materials and changes in regulatory policies are the major restraints on the live cell encapsulation market.

Leading players in the live cell encapsulation market include Balchem Corporation, Sernova Corporation, Blacktrace Holdings Ltd., Merck, Neurotech Holdings LLC, Living Cell Technologies, MiKroCaps, and Biotime Inc., among others.

This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.